Literature DB >> 25753501

Pleural puncture that excludes the ablation zone decreases the risk of pneumothorax after percutaneous microwave ablation in porcine lung.

Kyungmouk Steve Lee1, Haruyuki Takaki1, Hooman Yarmohammadi1, Govindarajan Srimathveeravalli1, Kerith Luchins2, Sébastien Monette3, Sreejit Nair1, Sirish Kishore1, Joseph P Erinjeri4.   

Abstract

PURPOSE: To test the hypothesis that the geometry of probe placement with respect to the pleural puncture site affects the risk of pneumothorax after microwave (MW) ablation in the lung.
MATERIALS AND METHODS: Computed tomography-guided MW ablation of the lung was performed in 8 swine under general anesthesia and mechanical ventilation. The orientation of the 17-gauge probe was either perpendicular (90°) or parallel (< 30°) with respect to the pleural puncture site, and the ablation power was 30 W or 65 W for 5 minutes. After MW ablation, swine were euthanized, and histopathologic changes were assessed. Frequency and factors affecting pneumothorax were evaluated by multivariate analysis.
RESULTS: Among 62 lung MW ablations, 13 (21%) pneumothoraces occurred. No statistically significant difference was noted in the rate of pneumothorax between the perpendicular and the parallel orientations of the probe (31% vs 14%; odds ratio [OR], 2.8; P = .11). The pneumothorax rate was equal for 65-W and 30-W ablation powers (21% and 21%; OR, 1.0; P = .94). Under multivariate analysis, 2 factors were independent positive predictors of pneumothorax: ablation zone inclusive of pleural insertion point (OR, 7.7; P = .02) and time since intubation (hours) (OR, 2.7; P = .02).
CONCLUSIONS: Geometries where the pleural puncture site excluded the ablation zone decreased pneumothorax in swine undergoing MW ablation in the lung. Treatment planning to ensure that the pleural puncture site excludes the subsequent ablation zone may reduce the rate of pneumothorax in patients undergoing MW ablation in the lung.
Copyright © 2015 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25753501      PMCID: PMC5652064          DOI: 10.1016/j.jvir.2015.01.016

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  23 in total

1.  Microwave lung ablation complicated by bronchocutaneous fistula: case report and literature review.

Authors:  James T Bui; Ron C Gaba; M Grace Knuttinen; Benedictta O Omene; Andrew Shon; Brandon K Martinez; Charles A Owens
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

2.  Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model.

Authors:  Christopher L Brace; J Louis Hinshaw; Paul F Laeseke; Lisa A Sampson; Fred T Lee
Journal:  Radiology       Date:  2009-03-31       Impact factor: 11.105

3.  Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms.

Authors:  Takuji Yamagami; Takeharu Kato; Tatsuya Hirota; Rika Yoshimatsu; Tomohiro Matsumoto; Tsunehiko Nishimura
Journal:  J Vasc Interv Radiol       Date:  2006-10       Impact factor: 3.464

4.  The pathophysiology of tension pneumothorax in ventilated swine.

Authors:  E D Barton; P Rhee; K C Hutton; P Rosen
Journal:  J Emerg Med       Date:  1997 Mar-Apr       Impact factor: 1.484

5.  Chest wall temperature during radiofrequency ablation in a normal rabbit lung model.

Authors:  Tomohisa Okuma; Toshiyuki Matsuoka; Akira Yamamoto; Shinichi Hamamoto; Ken Kageyama; Kenji Nakamura; Yukio Miki
Journal:  Jpn J Radiol       Date:  2010-01-30       Impact factor: 2.374

6.  Major complications after lung microwave ablation: a single-center experience on 204 sessions.

Authors:  Aimin Zheng; Xiuwen Wang; Xia Yang; Weibo Wang; Guanghui Huang; Yonghao Gai; Xin Ye
Journal:  Ann Thorac Surg       Date:  2014-05-01       Impact factor: 4.330

Review 7.  Ventilator-induced lung injury: lessons from experimental studies.

Authors:  D Dreyfuss; G Saumon
Journal:  Am J Respir Crit Care Med       Date:  1998-01       Impact factor: 30.528

8.  Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.

Authors:  Tomohisa Okuma; Toshiyuki Matsuoka; Akira Yamamoto; Yoshimasa Oyama; Masami Toyoshima; Kenji Nakamura; Yuichi Inoue
Journal:  Cardiovasc Intervent Radiol       Date:  2007-11-06       Impact factor: 2.740

9.  High-powered percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: a preliminary study.

Authors:  Howard Liu; Karin Steinke
Journal:  J Med Imaging Radiat Oncol       Date:  2013-05-08       Impact factor: 1.735

Review 10.  Pneumothorax.

Authors:  Michael H Baumann; Marc Noppen
Journal:  Respirology       Date:  2004-06       Impact factor: 6.424

View more
  4 in total

1.  High power microwave ablation of normal swine lung: impact of duration of energy delivery on adverse event and heat sink effects.

Authors:  Hiroshi Kodama; Eisuke Ueshima; Song Gao; Sebastien Monette; Lee-Ronn Paluch; Kreg Howk; Joseph P Erinjeri; Stephen B Solomon; Govindarajan Srimathveeravalli
Journal:  Int J Hyperthermia       Date:  2018-04-18       Impact factor: 3.914

Review 2.  Microwave Ablation in Primary Lung Malignancies.

Authors:  Amgad M Moussa; Etay Ziv; Stephen B Solomon; Juan C Camacho
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

Review 3.  Decision Making in Interventional Oncology: Ablative Options in the Lung.

Authors:  Kyungmouk Steve Lee; Joseph P Erinjeri
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

4.  Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study.

Authors:  Paul B Shyn; Florian J Fintelmann; Konstantin S Leppelmann; Vincent M Levesque; Alexander C Bunck; Alexis M Cahalane; Michael Lanuti; Stuart G Silverman
Journal:  Ann Surg Oncol       Date:  2021-02-23       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.